Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Reexamination Certificate
2007-07-28
2008-12-30
Sheikh, Humera N (Department: 1618)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
C424S464000, C424S489000
Reexamination Certificate
active
07470434
ABSTRACT:
A method of blocking microbial adherence to a eukaryotic cell surface in a mammal by applying a pharmacologically acceptable composition containing at least one compound selected from the group consisting of isoleucine, an active isomer thereof, and an active analog thereof, to said surface in a microbial blocking quantity. Also, compositions for achieving the above blocking of microbial adherence.
REFERENCES:
patent: 6607711 (2003-08-01), Pedersen
patent: 6770306 (2004-08-01), Zeng
Arvola T., Laiho K, Torkkeli S, Mykkanen H., Salminem S., Maunula L, and Isolauri E. ProphylacticLactobacillusGG reduces antibiotic-associated diarrhea in children with respiratory infections:a randomized study. Pediatrics 104, e64, 1999.
Boris S and Barbes C. Role played bylactobacilliin controlling the population of vaginal pathogens. Microbes Infect. 2, 543-546, 2000.
Brighenti F, Casiraghi MC, Canzi E, and Ferrari A. Effect of consumption of a ready-to eat breakfast cereal containing inulin on the intestinal milieu and blood lipids in healthy male voluteers, European Journal of Clinical Nutrition 53, 726-733, 1999.
Du Toit M, Franz CM, Dicks, LM, Schillinger U., Haberer P, Warlies B., Ahrens F, and Holzapfel W.H. Characterization and selection of probioticlactobacillifor a preliminary minipig feeding trial and their effect on serum cholesterol levels, faeces pH and faeces moisture content. Int. J. Food Microbiol. 40, 93-104, 1998.
Gionchetti P., Rizzello F., Venturi A., Brigidi P., Matteuzzi D, Bazzocchi , Poggioli G., Miglioli M., and Campieri M. Oral bacteriotherapy as a maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.Gastroentrology 119, 305-309, 2000.
Guanalini S, Pensabebene L, Zikri MA, Dias JA, Casali LG, Hoekstra , Kolacek S, Massar K, Micetic-Turk D, Papadopoulou A, de Sousa JS, Sandhu B, Szajewska H, Weizman Z. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J. Pediatr. Gastroenterol. Nutr. 30. 54-60, 2000.
Kelly CG and Younson JS. Anti-adhesive strategies in the prevention of infectious disease at mucosal surfaces. Expert Opin. Investig. Drugs 9, 1711-1721, 2000.
Martin H.L., Richardson, B.A., Nyange, P.M., Lavreys, L., Hillier S.L., Chohan B., Mandaliya K., Ndirrya-Achola J.O., Bwayo J. and Kreiss J. Vaginallactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J. Infect. Dis. 180, 1863-1868, 1999.
Merz AJ and So M. Interactions of pathogenic Neisseriae with epithelial cell membranes. Annu. Rev. Cell. Dev. Biol. 16, 423-457, 2000.
Mohan B., Kadirvel A., Natarajan A. and Bhaskaran M. Effect of probiotic supplementation on growth, nitrogen utilization and serum cholesterol in boilers. British Poulrty Science 37, 395-401, 1996.
Mulvey MA, Schilling JD, Martinez JJ, Hulgren, SJ. From the cover: bad bugs and beleagered bladders: interplay between uropathogenicEscherchia coiand innate host defenses. Proc. Natl. Acad. Sci. USA 97, 8829-8835, 2000.
Nobaek S., Johansson M-L., Molin G., Ahrne S., and Jeppsson B. Alteration of intestinal microflora is associated with a reduction in abdominal bloating and pain in patients with irritable bowel syndrome. American Journal of Gastroenterology 1231-1238, 2000.
Petro T.M and Bhattacharjee J.K. Effect of dietary amino acid limitations upon native levels of murine immunoglobulins, transferrin, and complement. Infect. Immun. 27, 513-518, 1980.
Petro T.M and Bhattacharjee J.K. Effect of dietary amino acid limitations upon the susceptibility toSalmonella typhimuriumand the effect upon humoral and cellular immune responses in mice. Infect. Immun. 32, 251-259, 1981.
Reid, G. Potential preventive strategies and therapies in urinary tract infection. World J. Urol. 17, 359-363, 1999.
Sobel, J. Bacterial Vaginosis. Annu. Rev. Med. 51, 349-356, 2000.
Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, and Young, RJ.LactobacillusGG in the prevention of antibiotic-associated diarrhea in children. Journal of Pediatrics 135, 564-568, 1999.
Venturi A., Gionchetti P., Rizzello F., Johansson R., Zucconi E., Brigidi P., Matteuzzi D., and Campieri M. Impact on the composition of the faecal flora by a new probiotic preparation; preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment. Pharmacol. Ther. 13, 1103-1108, 1999.
Anderson Glenn M
Zasloff Michael A
Millson, Jr. Henry E.
Sheikh Humera N
LandOfFree
Methods and compositions for blocking microbial adherence to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for blocking microbial adherence to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for blocking microbial adherence to... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4045507